The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
Why are the three healthcare stocks highlighted in today’s article worth a look? Because not only are some top healthcare sector analysts bullish on them,… Read More »Some Top Healthcare Analysts Are Bullish On These 3 Stocks
One of the most significant – and relatively recent – innovations in the treatment of cancer are so-called immuno-oncology (IO) drugs. As today’s article explains,… Read More »The Pharmaceutical Companies Experiencing Early Success With These “Miracle” Cancer Drugs
More than 10 years into this bull market, Buy and Outperform analyst ratings generally come with implied upside potential of 8% to 10%. However, the… Read More »20 Biotech And Pharma Stocks Offering More-Than-Your-Average Upside Potential